Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBH589 in Relapsed/Refractory CLL and MCL
NCT01090973Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Mar 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), sponsored by Moffitt Cancer Center. Started Mar 2010; status: terminated.
02
Drugs
panobinostat
03
Conditions
chronic lymphocytic leukemia (CLL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01090973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090973.